DOLFINES (ALDOL.PA) Fundamental Analysis & Valuation

EPA:ALDOL • FR001400SP13

Current stock price

1.115 EUR
-0.08 (-7.08%)
Last:

This ALDOL.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. ALDOL.PA Profitability Analysis

1.1 Basic Checks

  • ALDOL had negative earnings in the past year.
ALDOL.PA Yearly Net Income VS EBIT VS OCF VS FCFALDOL.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2024 -1M -2M -3M -4M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -5.53%, ALDOL is doing worse than 89.19% of the companies in the same industry.
  • ALDOL has a Return On Equity of -9.43%. This is amonst the worse of the industry: ALDOL underperforms 89.19% of its industry peers.
Industry RankSector Rank
ROA -5.53%
ROE -9.43%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALDOL.PA Yearly ROA, ROE, ROICALDOL.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2024 -20 -40 -60 -80 -100

1.3 Margins

  • With an excellent Gross Margin value of 106.40%, ALDOL belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
  • ALDOL's Gross Margin has been stable in the last couple of years.
  • ALDOL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 106.4%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.71%
GM growth 5Y0.19%
ALDOL.PA Yearly Profit, Operating, Gross MarginsALDOL.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2024 0 50 -50 100

3

2. ALDOL.PA Health Analysis

2.1 Basic Checks

  • ALDOL has less shares outstanding than it did 5 years ago.
ALDOL.PA Yearly Shares OutstandingALDOL.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2024 5M 10M 15M
ALDOL.PA Yearly Total Debt VS Total AssetsALDOL.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2024 2M 4M 6M 8M

2.2 Solvency

  • ALDOL has an Altman-Z score of 1.56. This is a bad value and indicates that ALDOL is not financially healthy and even has some risk of bankruptcy.
  • ALDOL has a Altman-Z score (1.56) which is comparable to the rest of the industry.
  • A Debt/Equity ratio of 0.27 indicates that ALDOL is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.27, ALDOL is in the better half of the industry, outperforming 64.86% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF N/A
Altman-Z 1.56
ROIC/WACCN/A
WACCN/A
ALDOL.PA Yearly LT Debt VS Equity VS FCFALDOL.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2024 1M 2M 3M 4M 5M

2.3 Liquidity

  • ALDOL has a Current Ratio of 1.81. This is a normal value and indicates that ALDOL is financially healthy and should not expect problems in meeting its short term obligations.
  • ALDOL has a better Current ratio (1.81) than 62.16% of its industry peers.
  • ALDOL has a Quick Ratio of 1.81. This is a normal value and indicates that ALDOL is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.81, ALDOL is in the better half of the industry, outperforming 70.27% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.81
Quick Ratio 1.81
ALDOL.PA Yearly Current Assets VS Current LiabilitesALDOL.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2024 1M 2M 3M 4M 5M

1

3. ALDOL.PA Growth Analysis

3.1 Past

  • The Revenue has been growing by 10.64% on average over the past years. This is quite good.
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-303.09%
Revenue 1Y (TTM)N/A
Revenue growth 3Y29.09%
Revenue growth 5Y10.64%
Sales Q2Q%115.67%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-100%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year45.47%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALDOL.PA Yearly Revenue VS EstimatesALDOL.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
ALDOL.PA Yearly EPS VS EstimatesALDOL.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600

0

4. ALDOL.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • ALDOL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALDOL.PA Price Earnings VS Forward Price EarningsALDOL.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALDOL.PA Per share dataALDOL.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. ALDOL.PA Dividend Analysis

5.1 Amount

  • ALDOL does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

ALDOL.PA Fundamentals: All Metrics, Ratios and Statistics

DOLFINES

EPA:ALDOL (4/8/2026, 7:00:00 PM)

1.115

-0.08 (-7.08%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)10-27
Earnings (Next)04-28
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap2.77M
Revenue(TTM)10.00M
Net Income(TTM)-510.00K
Analysts84.44
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.28
P/FCF N/A
P/OCF N/A
P/B 0.51
P/tB 3.41
EV/EBITDA N/A
EPS(TTM)-0.21
EYN/A
EPS(NY)0
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS4.03
BVpS2.18
TBVpS0.33
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -5.53%
ROE -9.43%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 106.4%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.71%
GM growth 5Y0.19%
F-ScoreN/A
Asset Turnover1.08
Health
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.81
Quick Ratio 1.81
Altman-Z 1.56
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-303.09%
EPS Next Y-100%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3Y29.09%
Revenue growth 5Y10.64%
Sales Q2Q%115.67%
Revenue Next Year45.47%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year3088.14%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

DOLFINES / ALDOL.PA Fundamental Analysis FAQ

What is the fundamental rating for ALDOL stock?

ChartMill assigns a fundamental rating of 1 / 10 to ALDOL.PA.


What is the valuation status of DOLFINES (ALDOL.PA) stock?

ChartMill assigns a valuation rating of 0 / 10 to DOLFINES (ALDOL.PA). This can be considered as Overvalued.


How profitable is DOLFINES (ALDOL.PA) stock?

DOLFINES (ALDOL.PA) has a profitability rating of 1 / 10.


What is the earnings growth outlook for DOLFINES?

The Earnings per Share (EPS) of DOLFINES (ALDOL.PA) is expected to decline by -100% in the next year.